EUVIMEDEUVIMED entdecken
Multizentrische Studie

Ability of CHA2DS2‐VASc/R2CHA2DS2‐VASc Scores to Predict Complications Related to Cardiac Implantable Electronic Devices

Serdar Söner iD, Adem Aktan, Raif Kılıç, Hamdullah Güzel, Ercan Taştan, Metin Okşul, Adnan Duha Cömert, Mehmet Sait Coşkun, Hülya Tosun Söner, Mehmet Özbek, Muhammed Demir iD, Tuncay Güzel iD

Pacing and Clinical Electrophysiology · 2025

DOI: 10.1111/pace.15148 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Pacing and Clinical Electrophysiology, 2025. Verfasst von Serdar Söner und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Health Science University, Gazi Yaşargil Training and Research Hospital, Diyarbakır, Turkey. Hauptthemen laut MEDLINE: Defibrillators, Implantable, Pacemaker, Artificial, Postoperative Complications. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Globally, the number of cardiac implantable electronic devices (CIEDs) is increasing. In our study, we aimed to investigate whether CHA 2 DS 2 ‐VASc and R 2 CHA 2 DS 2 ‐VASc scores are predictive of CIED‐related complications.

Methods

Our investigation was carried out with a multicenter retrospective design. Patients who underwent CIED surgery at two cardiac centers in Turkey between January 2011 and May 2023, 1676, were evaluated. The patients were divided into two groups according to their R 2 CHA 2 DS 2 ‐VASc scores. Patients with R 2 CHA 2 DS 2 ‐VASc ≥ 5 were included in group 1 (380 patients), and patients with R 2 CHA 2 DS 2 ‐VASc < 5 (1296 patients) were included in group 2. The primary outcome was defined as the cumulative events. Each component of cumulative events, such as hematoma, pericardial effusion, pneumothorax, and infection, was also defined as a secondary outcome.

Results

The study's patient population had an average age of 62.9 ± 14 years. Pneumothorax (1.8% vs. 1.3%, p = 0.444), pericardial effusion or tamponade (0.35% vs. 0.2%, p = 0.659), and clinically significant hematoma (1.1% vs. 0.6%, p = 0.376) were comparable between the groups. Infection‐related devices and cumulative events classified as primary outcomes were higher in the R 2 CHA 2 DS 2 ‐VASc ≥ 5 group (6.1% vs. 1.2%, p < 0.001; 7.6% vs. 3.2%, p < 0.001, respectively). Modeling analyses showed that the CHA 2 DS 2 ‐VASc score and HT were also independent predictors of device‐related infection and cumulative events.

Conclusion

In the R 2 CHA 2 DS 2 ‐VASc ≥ 5 groups, infection related to the device system and cumulative events were higher. Patients with an R 2 CHA 2 DS 2 ‐VASc score of 5 or more and a high CHA 2 DS 2 ‐VASc score should be evaluated more carefully regarding infection and cumulative events before and after the operation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Defibrillators, ImplantablePacemaker, ArtificialPostoperative ComplicationsHumansMaleFemaleRetrospective StudiesMiddle AgedRisk AssessmentAgedTurkey

Stichwörter der Autor:innen

CHA2DS2‐VASc ScoreR2CHA2DS2‐VASc scorecardiac implantable electronic devicecomplicationinfection

Autor:innen und Institutionen

  • Department of Cardiology, Health Science University, Gazi Yaşargil Training and Research Hospital, Diyarbakır, Turkey.
  • Department of Cardiology, Mardin Artuklu University, Mardin, Turkey.
  • Department of Cardiology, Çermik State Hospital, Diyarbakır, Turkey.
  • Department of Cardiology, Düzce University Faculty of Medicine, Düzce, Turkey.
  • Department of Cardiology, Ergani State Hospital, Diyarbakır, Turkey.
  • Department of Anesthesiology and Reanimation, Health Science University, Gazi Yaşargil Training and Research Hospital, Diyarbakır, Turkey.

ORCID-Profile: Serdar Söner, Muhammed Demir, Tuncay Güzel

Zitieren

APA

Söner, S., Aktan, A., Kılıç, R., Güzel, H., Taştan, E., Okşul, M., Cömert, A. D., Coşkun, M. S., Söner, H. T., Özbek, M., Demir, M., & Güzel, T. (2025). Ability of CHA2DS2‐VASc/R2CHA2DS2‐VASc Scores to Predict Complications Related to Cardiac Implantable Electronic Devices. Pacing and Clinical Electrophysiology. https://doi.org/10.1111/pace.15148

Vancouver

Söner S, Aktan A, Kılıç R, Güzel H, Taştan E, Okşul M, et al. Ability of CHA2DS2‐VASc/R2CHA2DS2‐VASc Scores to Predict Complications Related to Cardiac Implantable Electronic Devices. Pacing and Clinical Electrophysiology. 2025. doi:10.1111/pace.15148

BibTeX
@article{Sner2025,
  author = {Söner, Serdar and Aktan, Adem and Kılıç, Raif and Güzel, Hamdullah and Taştan, Ercan and Okşul, Metin and Cömert, Adnan Duha and Coşkun, Mehmet Sait and Söner, Hülya Tosun and Özbek, Mehmet and Demir, Muhammed and Güzel, Tuncay},
  title = {Ability of CHA2DS2‐VASc/R2CHA2DS2‐VASc Scores to Predict Complications Related to Cardiac Implantable Electronic Devices},
  journal = {Pacing and Clinical Electrophysiology},
  year = {2025},
  doi = {10.1111/pace.15148}
}
Kostenlos starten →